The acquisition will enhance the capabilities of both the organization and lead to widespread unique infusion therapy.
Boyne Capital; a private equity firm has announced that it has acquired a majority interest in Infusion Associates Management, Inc.n (IAM), a newly formed management services organization that will oversee a network of ambulatory infusion clinics across the Midwestern US.
Khan Nedd, Infusion Associates’ Founder and Medical Director, stated, “Infusion Associates is poised for significant growth, with immediate opportunities to expand into new markets and capitalize on pent up demand being driven by cost reduction and demographic trends. Boyne is the right partner to help us take this platform to the next level and bring our unique infusion therapy delivery model to patients across the state of Michigan and beyond.”
In conjunction with the transaction, IAM has entered into a strategic partnership with Infusion Associates, PLLC, a leading provider of ambulatory infusion services to patients in the Western Michigan market. IAM will support the continued growth of the Practice both locally and into new markets, as well as enter into future partnerships with leading ambulatory infusion providers in the Midwest region.
The deal aims growing capabilities in order to reach more patients
Derek McDowell, Managing Partner and CEO, Boyne, stated, “Infusion Associates is a market leader in an emerging healthcare delivery channel with a long track record of providing high quality patient care in a low-cost ambulatory setting. We are pleased to be partnering with Joseph Herrod and Dr. Nedd in building upon an already strong foundation to expand the platform’s service footprint and grow capabilities, reaching more patients that are in need of infusion therapy.”
After transaction, IAM will be led by CEO Joseph Herrod. While speaking of the deal, he said “Boyne has proven to be a valuable partner in evaluating this opportunity and working through a number of complex deal dynamics throughout the course of the process, and Boyne’s continued support will provide the opportunity for Infusion Associates to dramatically accelerate investment in and expansion of capabilities going forward.”
Headquartered in Grand Rapids, Michigan, Infusion Associates is one of the leading ambulatory infusion practices in the Midwest, administering more than 15,000 treatments annually across various chronic conditions including Crohn’s Disease, ulcerative colitis, multiple sclerosis, rheumatoid arthritis, and a number of rare genetic diseases.
